Design and Testing of Stimulation and Myoelectric Recording Modules in an Implanted Distributed Neuroprosthetic System.
Nathaniel Makowski, Alexandru Campean, Joris Lambrecht...
https://pubmed.ncbi.nlm.nih.gov/33729949/Actively Recruiting
Led by Anne Bryden · Updated on 2025-12-19
30
Participants Needed
1
Research Sites
156 weeks
Total Duration
Researchers are evaluating a fully implanted neuroprosthetic system designed to restore hand function, reach, and trunk control in individuals with cervical spinal cord injuries. The goal is to improve multiple body functions such as grasp, reach, bed mobility, posture, cough, and bladder control, enhancing independence and quality of life. This research builds on 30 years of clinical experience with neuroprosthetic devices for spinal cord injury patients. Participants receive the Networked Neuroprosthetic System NNPS, a modular and scalable implanted device network that supports multiple functions simultaneously. The system is surgically implanted and tailored to each individuals needs to maximize functional gains. After implantation, participants undergo functional training and assessments to evaluate the systems impact on motor abilities. During the study, participants will be monitored through various tests including the Activities of Daily Living Abilities Test three months after implant and the Grasp-Release Test before and three months post-implant. Researchers will assess improvements in daily function as well as safety and overall health outcomes. The study involves a coordinated team approach to support participants throughout the treatment and evaluation process.
CONDITIONS
Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Anne Bryden
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Implanted networked neuroprosthesis | Current rehabilitation therapy (with or without FES) |
|---|---|---|
| What is it? | An implanted neuroprosthetic system that uses distributed stimulation and myoelectric sensing modules, designed to restore grasp and trunk functions by activating upper extremity and trunk muscles below the site of a cervical spinal cord injury. | Standard rehabilitation involves individualized physical and occupational therapy and may include surface-applied functional electrical stimulation (FES) to support muscle activation, with the aim of improving upper limb and trunk function after cervical spinal cord injury. |
| Role in this study | Participants receive the implantable neuroprosthetic device as the sole experimental treatment during the trial. | Conventional rehabilitation is provided as the standard of care for people with cervical spinal cord injury outside of the experimental trial setting. |
| Primary clinical use | The device is intended to restore voluntary grasp and trunk movement to enhance daily living abilities for people with cervical spinal cord injury. | Standard rehabilitation focuses on maximizing independence in activities of daily living and improving arm and trunk strength using therapy and surface FES where appropriate. |
| How is it given or performed? | Surgical implantation of stimulation and sensing modules into muscles, followed by personalized post-surgical programming and rehabilitation to support the use of the device in daily tasks. | Usually involves regular outpatient physical and occupational therapy sessions; surface-based FES is applied using external electrodes to stimulate the appropriate muscles as part of therapy. |
| Evidence status | Efficacy and safety are under clinical investigation; published results for this specific device in this population are not yet established. | Efficacy of conventional therapy and surface FES for upper limb/trunk rehabilitation is supported by published studies, though functional recovery remains limited for many after cervical spinal cord injury. |
| Important limitations | There is no established long-term outcome or safety data for this specific networked implantable system. Surgical risks, device-specific complications, and individual variability in motor response must be considered. | Standard rehabilitation and surface FES have demonstrated benefits, but most people with cervical spinal cord injury still experience substantial limitations in hand and trunk function post-therapy. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants undergo evaluation to ensure they meet criteria, including diagnosis confirmation and medical stability.
Duration - Single surgical procedure with immediate recovery period
Participants receive the implanted networked neuroprosthetic system for hand, arm, and trunk function through surgery.
1 implantation visit (in-person) followed by immediate post-operative care
Duration - Up to 3 months post-implant
Participants undergo functional training and assessments to evaluate and maximize regained motor functions.
Multiple visits for functional training and assessments over 3 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Nathaniel Makowski, Alexandru Campean, Joris Lambrecht...
https://pubmed.ncbi.nlm.nih.gov/33729949/Kevin L Kilgore, Harry A Hoyen, Anne M Bryden...
https://pubmed.ncbi.nlm.nih.gov/18406958/Chester H Ho, Ronald J Triolo, Anastasia L Elias...
https://pubmed.ncbi.nlm.nih.gov/25064792/P Hunter Peckham, Kevin L Kilgore
https://pubmed.ncbi.nlm.nih.gov/23481680/Anne Bryden
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor